semaglutide news october 16 2025 Ozempic's Patent Protection Starts to Expire in 2026. What Next? FDA approves Wegovy pill |

Sergey Terushkin, MD, FACS Peptide therapy has become a common topic among patients interested in recovery, healthy aging, sleep, energy, and body composition

The most striking recent piece of evidence came from a 2026 study published in Cell Metabolism [12], which found that semaglutide appeared to reverse cartilage damage in a mouse model of osteoarthritis, and crucially, this effect was independent of weight loss

3,55,6668 Several large population-based studies have also shown an association between elevated TSH levels and higher risk of incident CKD and CKD progression, 41,42,69 an in one rigorous study of non-dialysis dependent CKD (NDD-CKD) patients with subclinical hypothyroidism, those treated with exogenous thyroid hormone replacement had an amelioration of eGFR decline over time

some heat or tingling as well as my downtime after each treatment